T&R Biofab Obtains Patent Rights for Artificial Blood Vessel Manufacturing Method
[Asia Economy Reporter Kum Boryeong] T&R Biofab announced on the 26th that it has acquired a patent related to the '3D printing system for artificial blood vessel manufacturing and the method for manufacturing artificial blood vessels using the same.'
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Woman Experiences Eye Protrusion After 20 Years of Contraceptive Injections, Plans Lawsuit Against Major Pharmaceutical Company
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
T&R Biofab stated, "This patent pertains to polymer printing technology for external shape fixation and cell printing technology for fine vascular tissues," adding, "Since precise micro-pattern implementation is possible, it can be applied to the production of implantable tubular artificial tissues such as artificial blood vessels, airways, and esophagus."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.